Literature DB >> 12007590

Polymorphism of CTLA-4 gene at position 49 of exon 1 may be associated with schizophrenia in the Korean population.

Tae-Youn Jun1, Chi-Un Pae, Jeong-Ho Chae, Won-Myong Bahk, Kwang-Soo Kim, Hoon Han.   

Abstract

This study was carried out to investigate the association of a polymorphism of the CTLA-4 gene, at position 49 of exon 1, with schizophrenia in the Korean population. Among Korean patients diagnosed with schizophrenia according to DSM-IV, 116 patients who met the selection criteria were recruited for the study. One hundred and forty-nine normal healthy Koreans from the Catholic Hemopoietic Stem Cell Information Bank, were used as a normal control group. DNA was extracted from whole blood using proteinase K and the CTLA-4 gene region was amplified by polymerase chain reaction. Geneo typing was performed by single strand conformation polymorphism (SSCP). The genotype and allele distribution in patients with schizophrenia was significantly different from that seen in the control group. This study suggests a putative role of the CTLA-4 gene polymorphism at position 49 of exon 1 for schizophrenia in the Korean population, although the detailed mechanisms remained to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12007590     DOI: 10.1016/s0165-1781(02)00031-8

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  2 in total

1.  Evaluation of polymorphism, hypermethylation and expression pattern of CTLA4 gene in a sample of Iranian patients with schizophrenia.

Authors:  Dor Mohammad Kordi-Tamandani; Shahram Vaziri; Nahid Dahmardeh; Adam Torkamanzehi
Journal:  Mol Biol Rep       Date:  2013-05-11       Impact factor: 2.316

2.  Altered expression of mRNA profiles in blood of early-onset schizophrenia.

Authors:  Yong Xu; Yin Yao Shugart; Guoqiang Wang; Zaohuo Cheng; Chunhui Jin; Kai Zhang; Jun Wang; Hao Yu; Weihua Yue; Fuquan Zhang; Dai Zhang
Journal:  Sci Rep       Date:  2016-01-06       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.